The Role of Neoadjuvant Chemotherapy in NSCLC-Reference-Cited by-同舟云学术

The Role of Neoadjuvant Chemotherapy in NSCLC

Published:1996-05 Issue:5 Volume:109 Page:93S-95S
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Tonato Maurizio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference13 articles.

1. Induction therapy for NSCLC: a consensus report.;Klastersky;Lung Cancer,1991

2. The relationship of disease extent and cell type to survival in a clinical trial population.;Mountain;J Surg Oncol,1987

3. Induction chemotherapy for locally advanced non-small cell lung cancer.;Shepherd;Ann Thorac Surg,1993

4. Multimodality treatment for stage IIIA (N2) lung cancer: an overview.;Ginsberg;Chest,1993

5. Kris MG. Induction chemotherapy in the treatment of patients with stage IIIA (N2) non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center experience. In: Chemotherapy of non-small cell lung cancer: five years later. Proceedings of the Perugia International Cancer Conference IV, Perugia, Italy, 1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data;Cell & Bioscience;2023-06-08

2. The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data;2023-03-24

3. Non-small cell lung cancer: early stages;Annals of Oncology;2006-04

4. Docetaxel as neoadjuvant therapy for radically treatablestage III non-small-cell lung cancer: a multinational randomised phase III study;Annals of Oncology;2003-01

5. A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis;Lung Cancer;2001-12